Sandbox Financial Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,394
Closed -$523K 111
2024
Q3
$523K Sell
4,394
-1,588
-27% -$212K 0.19% 62
2024
Q2
$854K Buy
5,982
+3,747
+168% +$497K 0.33% 48
2024
Q1
$287K Buy
+2,235
New +$266K 0.12% 78

Other funds holding NVO

Sandbox Financial Partners's NVO Position: Q4 2024 in Review

Sandbox Financial Partners sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 4,394 shares — an estimated $523K sold.

Sandbox Financial Partners first reported a position in NVO in Q1 2024 and held it in 3 quarters. The position peaked at $854K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Sandbox Financial Partners reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Sandbox Financial Partners sold 4,394 Novo Nordisk shares in Q4 2024, an estimated $523K.
  • Sandbox Financial Partners first reported a position in Novo Nordisk in Q1 2024 and held it in 3 quarters.
  • Sandbox Financial Partners's Novo Nordisk position peaked at $854K in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Sandbox Financial Partners's 13F filing for Q4 2024, filed 15 Jan 2025.